Intrasplenic Thymus Organogenesis from Injectable Tissue Fragments Restores Functional T‐Cell Immunity
Advanced Science · 2026-11 · 13 (63)
DOI: 10.1002/advs.77358 ↗At a glance
Journal article in Advanced Science, published online on 2026-08-25. Written by Shaocong Wang and 10 co-authors. Institution: State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China. Major MEDLINE topics: Thymus Gland, T-Lymphocytes, Spleen, Organogenesis. 68 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, National Science and Technology Major Program, Fundamental Research Funds for the Central Universities.
Abstract (original language)
Thymic hypofunction due to primary defects, aging, infection, or cytoreductive therapies causes profound restriction of the T‐cell receptor (TCR) repertoire and increases rates of morbidity and mortality. Restoring thymic function is therefore critical. Here, the distinctive niche within the spleen has inspired the development of intrasplenic thymus regeneration (ISTR), an approach in which cultured thymic tissue fragments are implanted into the spleens of athymic nude mice, aged mice, thymectomized mice undergoing hematopoietic stem cell transplantation (HSCT), and humanized mice. The spleen's abundant vasculature and supportive stromal milieu enable rapid thymic organogenesis, leading to the reconstitution of phenotypically diverse and functional T‐cell compartments, as well as protective responses to viral and tumor challenges. Relative to intramuscular implantation, ISTR drives faster and more complete thymic development, generates greater T‐cell output, and is associated with a lower incidence of graft‐vs.‐host disease. In humanized animals, intrasplenic thymus grafts also promote the rapid emergence of functional human T cells. These results identify the spleen as an optimal ectopic niche for thymus regeneration and provide a promising strategy for clinical immune reconstitution and regenerative immunology.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China.
- National Resource Center for Mutant Mice, MOE Key Laboratory of Model Animal for Disease Study, Model Animal Research Center, Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, N…
- Wuxi Xishan Institute of Applied Biotechnology, Nanjing University, Wuxi, Jiangsu, China.
- Jiangsu Key Laboratory of Sericultural Biology and Biotechnology, School of Biotechnology, Jiangsu University of Science and Technology, Zhenjiang, Jiangsu, China.
- Faculty of Life Sciences & Medicine, King's College London, London, UK.
- Chemistry and Biomedicine Innovation Center (ChemBIC), ChemBioMed Interdisciplinary Research Center at Nanjing University, Nanjing, Jiangsu, China.
Funding
- National Natural Science Foundation of China
- National Science and Technology Major Program
- Fundamental Research Funds for the Central Universities
- Jiangsu Provincial Science and Technology Plan Special Fund
- Fundamental and Interdisciplinary Disciplines Breakthrough Plan of the Ministry of Education of China
Cite
APA
Wang, S., Zhang, Z., Dai, F., Yin, Z., Xing, Z., Li, Y., Lei, H., Zhang, J., Liu, C., Li, Y., & Dong, L. (2026). Intrasplenic Thymus Organogenesis from Injectable Tissue Fragments Restores Functional T‐Cell Immunity. Advanced Science, 13(63). https://doi.org/10.1002/advs.77358
Vancouver
Wang S, Zhang Z, Dai F, Yin Z, Xing Z, Li Y, et al. Intrasplenic Thymus Organogenesis from Injectable Tissue Fragments Restores Functional T‐Cell Immunity. Advanced Science. 2026;13(63). doi:10.1002/advs.77358
BibTeX
@article{Wang2026,
author = {Wang, Shaocong and Zhang, Zijian and Dai, Fulin and Yin, Zhijie and Xing, Zhen and Li, Yurong and Lei, Haochong and Zhang, Junfeng and Liu, Chunyan and Li, Yan and Dong, Lei},
title = {Intrasplenic Thymus Organogenesis from Injectable Tissue Fragments Restores Functional T‐Cell Immunity},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {63},
doi = {10.1002/advs.77358}
}
EUVIMED